Overview
What is Riaan Research Initiative Inc?
Riaan Research Initiative Inc, based in Oakland Gardens, New York, is a dedicated nonprofit organization that focuses on driving advancements in scientific research to generate treatments for severe and lethal neurodegenerative genetic disorders affecting the pediatric population, such as Cockayne Syndrome. Their mission is to create a world where every child with a fatal genetic disease has a pathway towards treatment. They achieve this by supporting the development of gene replacement therapy for Cockayne Syndrome and drug repurposing screens in partnership with researchers and academic institutions, issuing grants, and accelerating pre-clinical to clinical research studies for adeno-associated virus vectors. Furthermore, they provide education and resources to the medical and rare disease community, media, and public on scientific research advancements in Cockayne Syndrome, and maintain a patient registry to gather relevant clinical data for future trials.
Official website here: www.riaanresearch.org
Is Riaan Research Initiative Inc legitimate?
Riaan Research Initiative Inc is a legitimate nonprofit organization registered as a 501(c)(3) entity. Riaan Research Initiative Inc submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.riaanresearch.org
What is the mission statement of Riaan Research Initiative Inc?
The Riaan Research Initiative Inc is committed to creating a world where every child with a fatal genetic disease has a pathway towards treatment. They achieve this by promoting and advancing translational scientific research to advance treatments for severe and life-limiting genetic disorders, specifically focusing on neurodegenerative disorders that impact the pediatric population such as Cockayne Syndrome. The organization supports the development of gene replacement therapy for Cockayne Syndrome and drug repurposing screens by partnering with researchers and academic institutions, issuing grants, and accelerating the development of adenovirus vectors for pre-clinical to clinical research studies. Additionally, the Riaan Research Initiative Inc screens small molecules to identify drugs that can halt or reverse neurodegeneration in this patient population and provides education and resources to the medical and rare disease community, the media, and the general public on advancements in scientific research, Cockayne Syndrome awareness, and maintains a patient registry to gather relevant clinical data for future trials.
Official website here: www.riaanresearch.org
Who is the CEO of Riaan Research Initiative Inc?
Gurjot Kaur is the Founder/Chair of Riaan Research Initiative Inc.
Official website here: www.riaanresearch.org
What is the revenue of Riaan Research Initiative Inc?
Riaan Research Initiative Inc's revenue in 2022 was $1,515,797.
Official website here: www.riaanresearch.org
Who are the executives of Riaan Research Initiative Inc and what are their salaries?
There 11 volunteers at Riaan Research Initiative Inc.
Here are 3 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.riaanresearch.org
Where can I find the form 990 for Riaan Research Initiative Inc?
Riaan Research Initiative Inc's most recent form 990 was submitted in 2022 and can be accessed here.
Official website here: www.riaanresearch.org
Learn more at the official website: www.riaanresearch.org
Mission Statement of Riaan Research Initiative Inc
Riaan Research Initiative Inc is committed to creating a world where every child affected by fatal genetic diseases has a viable pathway towards treatment. This organization is dedicated to promoting and advancing translational scientific research to advance treatments for severe and life-threatening genetic disorders, particularly those affecting the pediatric population, such as Cockayne Syndrome.
In pursuit of its mission, Riaan Research Initiative supports various research projects. One of its primary areas of focus is the development of Cockayne Syndrome gene replacement therapy. The organization partners with researchers and academic institutions, issuing grants to accelerate this research. Additionally, Riaan Research Initiative engages in drug repurposing screens to identify small molecules that can halt or reverse neurodegeneration in this patient population.
The organization's gene therapy work involves accelerating the development of adenovirus vectors and supporting pre-clinical to clinical research studies. Simultaneously, Riaan Research Initiative's drug repurposing projects involve screening small molecules to identify drugs that can halt or reverse neurodegeneration in this patient population.
In its efforts to educate and inform, Riaan Research Initiative provides resources to the medical and rare disease community, the media, and the general public on advancements in scientific research related to Cockayne Syndrome. The organization also maintains a patient registry to gather relevant clinical data for future trials. By engaging in these activities, Riaan Research Initiative plays a vital role in raising awareness of Cockayne Syndrome and advancing research towards finding effective treatments.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
July, 2024
Riaan Research Initiative Inc is making a significant impact in the field of translational scientific research to advance treatments for severe and life-limiting genetic disorders, with a specific focus on pediatric populations affected by diseases like Cockayne Syndrome. Through research projects dedicated to gene replacement therapy, drug repurposing screens, and the acceleration of development in adenovirus vectors, the organization is actively working towards creating pathways for treatment for children with fatal genetic diseases. By issuing grants, partnering with researchers and academic institutions, and maintaining a patient registry, Riaan Research Initiative is not only advancing scientific knowledge but also raising awareness and providing resources to the medical community and the public. Their dedication to advancing treatments for genetic disorders demonstrates a commitment to improving the lives of those affected by these devastating diseases.
This information is meant to be a general summary of Riaan Research Initiative Inc. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Investment Income: $73
- Gross Receipts: $1,515,797
Assets and Liabilities:
- Total Assets: $1,140,975
- Total Liabilities: $0
- Net Assets: $1,140,975
Want to help this charity, for free? You can click here to learn more about Give Freely
Organization Details
Founding Year
2021
Phone
(561) 373-6487Principal Officer
Gurjot Kaur
Main Address
6123 224TH STREET, OAKLAND GARDENS, NY, 11364
Website
www.riaanresearch.orgNTEE Category
Code: G05 - Disease
If you are a representative of Riaan Research Initiative Inc and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.